CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 40 filers reported holding CTI BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,010,182 | -22.3% | 716,710 | +11.2% | 0.00% | – |
| Q4 2022 | $3,875,193 | -8.3% | 644,791 | -11.2% | 0.00% | -100.0% |
| Q3 2022 | $4,225,000 | -18.8% | 726,105 | -16.6% | 0.00% | 0.0% |
| Q2 2022 | $5,200,000 | +1438.5% | 871,096 | +1105.7% | 0.00% | – |
| Q1 2022 | $338,000 | +36.8% | 72,251 | -27.4% | 0.00% | – |
| Q4 2021 | $247,000 | -84.9% | 99,540 | -82.1% | 0.00% | – |
| Q3 2021 | $1,641,000 | -38.4% | 556,477 | -47.8% | 0.00% | – |
| Q2 2021 | $2,664,000 | -37.6% | 1,065,781 | -27.4% | 0.00% | -100.0% |
| Q1 2021 | $4,272,000 | +250.2% | 1,467,994 | +287.6% | 0.00% | – |
| Q4 2020 | $1,220,000 | +13455.6% | 378,780 | +8793.6% | 0.00% | – |
| Q3 2020 | $9,000 | +350.0% | 4,259 | +120.8% | 0.00% | – |
| Q2 2020 | $2,000 | -50.0% | 1,929 | -56.1% | 0.00% | – |
| Q1 2020 | $4,000 | -84.6% | 4,398 | -73.5% | 0.00% | – |
| Q4 2019 | $26,000 | +100.0% | 16,568 | +3.7% | 0.00% | – |
| Q3 2019 | $13,000 | +116.7% | 15,981 | +129.9% | 0.00% | – |
| Q2 2019 | $6,000 | -70.0% | 6,951 | -66.0% | 0.00% | – |
| Q1 2019 | $20,000 | -80.2% | 20,427 | -85.2% | 0.00% | – |
| Q4 2018 | $101,000 | -46.8% | 137,748 | +56.0% | 0.00% | – |
| Q3 2018 | $190,000 | -66.4% | 88,299 | -22.1% | 0.00% | – |
| Q2 2018 | $565,000 | +107.0% | 113,365 | +62.0% | 0.00% | – |
| Q1 2018 | $273,000 | +170.3% | 69,974 | +86.5% | 0.00% | – |
| Q4 2017 | $101,000 | -32.7% | 37,516 | -20.4% | 0.00% | – |
| Q3 2017 | $150,000 | +18.1% | 47,115 | +23.4% | 0.00% | – |
| Q2 2017 | $127,000 | -73.9% | 38,179 | -66.9% | 0.00% | – |
| Q1 2017 | $486,000 | – | 115,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |